Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MINNEAPOLIS, MINNESOTA--(Marketwired - May 20, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....
-
MINNEAPOLIS, MINNESOTA--(Marketwired - May 12, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ DiaMedica Inc....
-
MINNEAPOLIS, MINNESOTA--(Marketwired - May 8, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 25, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Further to its...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 22, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc. ("DiaMedica") (TSX...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 17, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 15, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company focused on the treatment of diabetes and its...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 7, 2014) - DiaMedica (TSX VENTURE:DMA) today announced the appointment of Mr. John Savage as the Company's Chief Financial Officer. Mr. Savage...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 19, 2014) - Minneapolis, Minnesota - DiaMedica (TSX VENTURE:DMA) announced that it has filed a Registration Statement on Form 20-F to register...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 5, 2014) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company, announced today that Mr. Rick Pauls, Chief Executive...